Hakan Doneray

Prof. Dr. Hakan Doneray

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2009 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
HDHakan Doneray
Hakan Doneray
ZOZerrin Orbak
Zerrin Orbak
LYLeyla Yildiz
Leyla Yildiz

1 October 2012 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
HDHakan Doneray
Hakan Doneray
IKIlknur Surucu Kara
Ilknur Surucu Kara
AKAkar Karakoc
Akar Karakoc
HTHuseyin Tan
Huseyin Tan
ZOZerrin Orbak
Zerrin Orbak

1 December 2007 in European Journal of Emergency Medicine
Verified
Journal Article
Closed access
HDHakan Doneray
Hakan Doneray
ZOZerrin Orbak
Zerrin Orbak
CKCahit Karakelleoglu
Cahit Karakelleoglu
Diagnosis of hyoscyamus niger intoxication is based on clinical symptomatology and history. Therapy includes stomach lavage, supportive therapy, and physostigmine as a specific antidote. Physostigmine is not available in Turkey. This retrospective study investigated the clinical outcomes in children with hyoscyamus niger intoxication who did not receive physostigmine therapy. Twenty-three children whose history and medical records indicated hyoscyamus niger intoxication were included the study. None of the cases had any abnormal laboratory findings. All the patients were performed gastric lavage and provided with supportive therapy. None of the children had any complications, and none required mechanical ventilation or died. All the patients were discharged in good health within 48 h. Our findings suggest that hyoscyamus niger intoxication in children is self-terminating and responds to supportive therapy and that routine use of physostigmine is unnecessary in every case with hyoscyamus niger intoxication.

1 May 2017 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
HDHakan Doneray
Hakan Doneray
EOElif Olcaysu
Elif Olcaysu
AYAbdulkadir Yildirim
Abdulkadir Yildirim
AOAyse Ozden
Ayse Ozden

20 January 2008 in Clinical Toxicology
Verified
Journal Article
Closed access
HDHakan Doneray
Hakan Doneray
BOBerker Ozkan
Berker Ozkan
ICIbrahim Caner
Ibrahim Caner
AOAsuman Ozkan
Asuman Ozkan
CKCahit Karakelleoglu
Cahit Karakelleoglu
In recent years, alendronate, an oral biphosphonate, has been added to therapy of hypercalcemia secondary to vitamin D intoxication in children. Alendronate may cause mucosal ulcerations in the mouth and esophagus. We report our experience in two infants with vitamin D intoxication to whom alendronate therapy was administered through nasogastric tube, an alternate route for alendronate administration.

1 September 2007 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
HDHakan Doneray
Hakan Doneray
HTHuseyin Tan
Huseyin Tan
MBMustafa Buyukavci
Mustafa Buyukavci
CKCahit Karakelleoglu
Cahit Karakelleoglu
In this study, clinical and demographic features of 16 cases with late vitamin K deficiency bleeding are presented. Ages of infants were between 30 and 130 days. Their delivery histories were uneventful, and family histories for bleeding disorders were negative. All parents except one were unaware of whether their children received vitamin K at birth or not. All cases did not have any underlying illness to explain the abnormal coagulation profile. The common presenting finding was pallor (62.5%). Intracranial haemorrhage was the most common bleeding site (37.5%), and two patients (12.5%) died because of it. Late vitamin K deficiency bleeding is still an important handicap in infants. Parents and healthcare providers should be informed about the importance of vitamin K prophylaxis to prevent vitamin K deficiency in infants.